For instance, TLR7 and TLR9 are often activated in therapies against viral infections and as adjuvants in cancer vaccines, while TLR2 and TLR4 are targeted by antagonists to mitigate inflammatory responses in sepsis and other inflammatory diseases [8]. The gene discussed is TLR9; the disease is cancer.